FDA User Fees Under Fire

Today, we’re tackling a question that maybe sounds straightforward, but could have complicated, unforeseen consequences. That question? What happens if the FDA stops collecting user fees from drug companies? At first glance, it sounds like a win. Less corporate influence, more independence for regulators. But is it really that simple? Read the full articleThe Cost of Free: What Removing FDA User Fees Could Mean for Drug Innovation and Public HealthAbout the authorMatt Quinn, Ph.D.